UNIVERSITY OF ROCHESTER

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1850-01-01

Employees: 10K

Market Cap: -

Website: http://www.rochester.edu

Clinical Trials

Gemcitabine, Oxaliplatin and Panitumumab in Kras/B-raf Wild-Type Biliary Track and Gallbladder Cancer

Phase 2

Completed

Conditions: Biliary Tract Cancer
Gallbladder Cancer

Interventions: Drug: Panitumumab
Drug: oxaliplatin
Drug: gemcitabine

First Posted Date: 2011-03-04

Last Posted Date: 2016-08-17

Lead Sponsor: University of Rochester

Target Recruit Count: 31

Registration Number: NCT01308840

Locations: 🇺🇸
Dana-Farber / Harvard Cancer Center, Boston, Massachusetts, United States
🇺🇸
University of Rochester Medical Center, Rochester, New York, United States

Effects of High Dose Calcitriol in Breast Cancer Patients

Phase 2

Completed

Conditions: Breast Cancer

Interventions: Drug: Calcitriol

First Posted Date: 2011-02-10

Last Posted Date: 2022-04-20

Lead Sponsor: University of Rochester

Target Recruit Count: 12

Registration Number: NCT01293682

Locations: 🇺🇸
University of Rochester, Rochester, New York, United States

Triclosan Toothpaste and Third Molar Surgery

Not Applicable

Completed

Conditions: Dry Socket
Wound Infection

First Posted Date: 2011-02-09

Last Posted Date: 2015-10-28

Lead Sponsor: University of Rochester

Target Recruit Count: 141

Registration Number: NCT01292343

Locations: 🇺🇸
University of Rochester Eastman Dental Center, Rochester, New York, United States

Pioglitazone in Early Parkinson's Disease

Phase 2

Completed

Conditions: Parkinson's Disease

Interventions: Drug: Pioglitazone
Drug: placebo

First Posted Date: 2011-01-20

Last Posted Date: 2015-10-14

Lead Sponsor: University of Rochester

Target Recruit Count: 210

Registration Number: NCT01280123

Locations: 🇺🇸
University of Southern California, Los Angeles, California, United States
🇺🇸
Johns Hopkins University, Baltimore, Maryland, United States
🇺🇸
The Parkinson's & Movement Disorder Institute, Fountain Valley, California, United States

and more 35 locations

Study of Carfilzomib and Vorinostat for Relapsed or Refractory Lymphoma

Phase 1

Completed

Conditions: Lymphoma

Interventions: Drug: Vorinostat

First Posted Date: 2011-01-13

Last Posted Date: 2015-12-03

Lead Sponsor: University of Rochester

Target Recruit Count: 20

Registration Number: NCT01276717

Locations: 🇺🇸
University of Rochester, Rochester, New York, United States
🇺🇸
Virginia Commonwealth University Massey Cancer Center, Richmond, Virginia, United States

Memantine for Recurrent Glioblastoma

Phase 2

Terminated

Conditions: Glioblastoma

Interventions: Drug: memantine

First Posted Date: 2010-12-15

Last Posted Date: 2015-12-10

Lead Sponsor: University of Rochester

Target Recruit Count: 4

Registration Number: NCT01260467

Locations: 🇺🇸
University of Rochester Medical Center, Rochester, New York, United States

The Qutenza Patch as Treatment for Disabling Treprostinil (Remodulin) Infusion Site Pain

Phase 2

Completed

Conditions: Pulmonary Hypertension
Pulmonary Arterial Hypertension

Interventions: Drug: Qutenza (8% capsaicin)

First Posted Date: 2010-12-15

Last Posted Date: 2016-04-21

Lead Sponsor: University of Rochester

Target Recruit Count: 6

Registration Number: NCT01260454

Locations: 🇺🇸
Mary M. Parkes Asthma Center, University of Rochester, Rochester, New York, United States

Oral Curcumin for Radiation Dermatitis

Phase 2

Completed

Conditions: Radiation-induced Dermatitis

Interventions: Drug: Placebo
Drug: Curcumin

First Posted Date: 2010-11-24

Last Posted Date: 2016-03-07

Lead Sponsor: University of Rochester

Target Recruit Count: 686

Registration Number: NCT01246973

Effect of Age and Prior Immunity to Response to Seasonal Influenza Vaccines in Children

Phase 4

Completed

Conditions: Influenza

Interventions: Biological: Live attenuated Influenza vaccine
Biological: TIV followed by LAIV
Biological: LAIV followed by TIV
Biological: Trivalent Influenza Vaccine

First Posted Date: 2010-11-24

Last Posted Date: 2016-12-29

Lead Sponsor: University of Rochester

Target Recruit Count: 34

Registration Number: NCT01246999

Locations: 🇺🇸
Dartmouth-Hitchcock Medical Center, Lebanon, New Hampshire, United States
🇺🇸
Vaccine Research Unit Room 3-5000, Rochester, New York, United States

Assessment of Prototype Hand-held Fundus Camera

Terminated

Conditions: Evaluate Performance of New Fundus Camera

First Posted Date: 2010-11-19

Last Posted Date: 2015-06-02

Lead Sponsor: University of Rochester

Target Recruit Count: 1

Registration Number: NCT01244412

Locations: 🇺🇸
Flaum Eye Institute-University of Rochester, Rochester, New York, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy